Late‐Stage Functionalization of Peptides on the Solid Phase Authors: Marius Werner, Truc Lam Pham, Franziska Thomas Published: 2026 ABSTRACT ABSTRACTChemical modification is a means of tailoring the structure and function of peptides. This is of particular interest in the field of peptide drug development. Methods that enable straightforward modification of peptides with non‐canonical residues are therefore in high demand. On‐resin late‐stage functionalization is a powerful, cost‐ and time‐efficient tool for modifying peptides. It also allows for high‐throughput experimentation, making it well suited to streamlining the development of peptide therapeutics. In this minireview, we provide an overview of the chemical approaches for on‐resin late‐stage peptide functionalization , most of which have been developed over the past decade. These reactions range from nucleophilic substitution and carbonyl chemistry to metal catalysis and photocatalysis. Many of the presented approaches have been shown to be compatible with short and long peptides, and to modulate their bioactivity. Impressive examples of peptide library synthesis in high‐throughput formats demonstrate the enormous potential of late‐stage peptide functionalization for the development of peptide therapeutics in the years to come.Keywords: late‐stage functionalization, non‐canonical amino acids, peptide therapeutics, peptides, solid phase peptide synthesis Introduction Peptides have long been considered an important class of therapeutics due to their wide range of functions [1, 2, 3, 4]. Their medium size, in particular, fills the gap between small molecules and biologics [5]. Compared to small molecules, they show an improved specificity, and they have better cell permeability and lower immunogenicity than biologics. Another advantage is that they are easily accessible via highly modular solid‐phase peptide synthesis (SPPS). The first and best‐known example of a peptide drug is insulin, which was approved in the 1920s to treat type 1 diabetes [6]. Since then, however, only a relatively small number of new peptide therapeutics have been approved. The main challenge in developing new peptide drugs is the low biostability of natural peptides, but this obstacle can be overcome through chemical modification [7, 8]. The traditional method of chemically modifying peptides involves synthesizing SPPS‐compatible building blocks from non‐natural amino acids [7]. Although this strategy permits the use of a wide range of chemical reactions to produce the building blocks, it is also highly labor‐intensive. Furthermore, only a limited number of non‐canonical amino acid building blocks are commercially available, and they are expensive. To create libraries of peptides with non‐canonical modifications in a cost‐ and time‐efficient manner, alternative approaches are required. One such strategy is the site‐selective modification of peptides after the peptide chain has been assembled. Ideally, this would be carried out in an aqueous solution on unprotected peptides using biorthogonal chemistry. However, chemical reactions that meet biorthogonality criteria are limited. A compromise that allows for a wide range of chemical reactions and straightforward, efficient peptide diversification is the late‐stage functionalization (LSF) of resin‐bound peptides (Figure 1). In this approach, an amino acid containing a reactive handle is introduced into the peptide sequence via SPPS. This can be either a canonical amino acid or an inexpensive, ideally commercially available, non‐canonical amino acid building block. This residue is then selectively modified by a variety of substrates, serving as a starting point for further diversification. Since LSF is performed on resin‐bound peptides that remain protected, a wide range of chemical reactions are tolerated, including those that occur under harsher conditions and in non‐aqueous solvents. Site‐selectivity is achieved through orthogonal protecting group strategies [9]. Thus, on‐resin LSF enables rapid and extensive access to chemical and structural diversity from a single starting material. Concept of on‐resin LSF compared to traditional SPPS with non‐canonical amino acid building blocks. Pioneering work on the LSF of resin‐bound peptides was described 20–30 years ago [10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22]. These early examples primarily focused on introducing natural post‐translational modifications, such as glycosylation and phosphorylation [10, 11, 12, 13]. Although examples of the introduction of non‐natural modifications were reported back then, there has been rising interest over the past decade in developing methods to introduce non‐canonical modifications into peptides at a late stage of synthesis, in recognition of their great potential for developing new peptide therapeutics [1, 2, 3, 4, 5, 7, 8]. As this is a relatively new trend, many reports focus on method development, and few have described its application in developing peptide therapeutics in parallel formats. However, all the methods described have the potential to be used in peptide diversification and thus in the development of peptide therapeutics. This minireview aims to highlight recent advances in this field and provide an overview of the chemical reactions that have been established for on‐resin LSF. We focus primarily on side chain modifications. Backbone modifications have mainly been performed in solution and are covered in detail elsewhere [23, 24]. Only a few on‐resin modifications of the peptide backbone have been described, and these are reviewed herein. Peptide macrocyclization and stapling have attracted considerable attention in the past, and numerous reviews on these topics have been published [25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35]. Therefore, we will only include examples of on‐resin peptide macrocyclization or stapling if they involve structural diversification beyond cyclization. We have structured the review according to the reaction classes, starting with nucleophilic substitution, followed by carbonyl chemistry and metal‐catalyzed reactions, redox reactions, pericyclic reactions, and photocatalysis. We have also included a short opening chapter to this review in which we outline some general considerations regarding on‐resin LSF. Before concluding the review, we provide a brief assessment of the potential of resin‐based LSF for the development of peptide therapeutics. In the Supporting Information, we provide some practical information on performing LSF on resin‐bound peptides. General Considerations in On‐Resin Late‐Stage Functionalization of Peptides The heterogeneity of LSF on the solid phase makes identifying the optimal synthesis conditions challenging. Conditions optimized for chemical reactions in solution cannot be applied directly to the solid phase, and numerous parameters must be considered. Below, we briefly discuss aspects of resin selection and protecting group strategies. More detailed information can be found in the Supporting Information. Resins and Linkers In solid‐phase synthesis, the swollen resin is considered the solvent. Consequently, the swelling behavior and polarity of a resin greatly influence chemical reactions carried out on resin, and must therefore be considered when developing new LSF methods. Polystyrene (PS) resin is most commonly used due to its cost‐effectiveness. However, it is highly nonpolar, resulting in good swelling in nonpolar solvents but poor swelling in alcohols and water. Conversely, polyethylene glycol (PEG) and polyacryl‐amide resins exhibit greater polarity and improved swelling in many solvents than PS resin, but have a lower loading density. While this is advantageous for synthesizing longer peptides, it can cause problems during scaling up. In general, solvents that induce strong swelling of the resin are better suited to synthesis. However, this is not a mandatory requirement as long as swelling is observed. For example, the amination of peptides containing iodohomoalanine on PS resin is more effective in acetonitrile than in dimethylformamide (DMF), although resin swelling is lower in acetonitrile [36]. Switching from PS resin to the higher‐swelling PEG resin does not necessarily lead to a higher yield. PS resin has been shown to give better yields in photocatalytic decarboxylative arylation than PEG resin [37], yet both types of resin can be used for the hydroboration of peptides modified with alkenes and alkynes [38]. The reaction conditions used in an LSF are determined by the peptide linkage to the resin and the protecting group strategy employed in SPPS [39, 40, 41]. The 9‐fluorenylmethoxycarbonyl (Fmoc)/tert‐butyl (t‐Bu) strategy is typically used, relying on acid‐sensitive side chain protecting groups and acid‐sensitive linkers. Therefore, basic reaction conditions are generally unproblematic, whereas acidic conditions cannot be considered. The Wang and Rink amide linkers that are usually employed exhibit good stability; however, acid‐stable alternatives, such as photolabile or safety‐catch linkers, can be considered if necessary. The latter are stable under various conditions, but become cleavable upon chemical activation [42]. Finally, when establishing new LSF methods, the conditions for peptide cleavage from the resin must also be taken into account. The use of strong acids and nucleophilic additives, such as triisopropylsilane or thiols, can induce undesired side reactions. Orthogonal Protecting Group Strategies In addition to the points outlined above, protecting group strategies must be carefully considered when planning an LSF to selectively target the reactive site within the peptide sequence to be modified. In LSF, amino acid building blocks bearing the required reactive groups are incorporated into the peptide sequence during SPPS. In most cases, an orthogonal side chain protecting group strategy is required to selectively address these residues, enabling the reactive groups to be deprotected while the side chains of the other amino acids in the peptide sequence remain protected. In standard Fmoc/t‐Bu protection group strategies, the functional groups of the amino acid side chains are protected using acid‐sensitive groups. Protecting groups that are typically considered to be orthogonal to standard side chain protecting groups in Fmoc/t‐Bu SPPS include allyl protecting groups, such as allyl esters for carboxylic acids or the allyloxycarbonyl (Alloc) group for amino groups, as well as highly acid‐sensitive groups, such as 4‐methyltrityl (Mtt), monomethoxytrityl (Mmt) or dimethoxytrityl (Dmt), which are used for the orthogonal protection of alcohols, thiols and amines [43, 44, 45, 46, 47, 48]. Allyl‐based protecting groups are cleaved under metal catalysis using Pd(0) and nucleophilic additives such as phenylsilane [43, 44, 45]. Deprotection generally proceeds smoothly; however, residual palladium catalyst on the resin can induce side reactions in subsequent steps. Conversely, highly acid‐sensitive groups are usually removed using a solution of 1% trifluoroacetic acid in dichloromethane [46, 47, 48]. While most protecting groups of the standard amino acid building blocks are stable under these conditions, partial deprotection of trityl‐protected cysteine has been observed [48]. Alternatively, photolabile protecting groups are available for most functional groups [49, 50]. Although deprotection occurs under light irradiation and neutral conditions, rendering them fully orthogonal to the Fmoc/t‐Bu protecting group strategy, low deprotection efficiencies and side reactions caused by photoproducts can sometimes be problematic. A variety of other protective groups are available that are compatible with the general conditions of SPPS. Examples include hydrazine‐sensitive groups such as 4‐(N‐[1‐(4,4‐dimethyl‐2,6‐dioxocyclohexylidene)‐3‐methylbutyl]amino)benzyl (Dmab) for carboxylic acids, 1‐(4,4‐dimethyl‐2,6‐dioxocyclohex‐1‐ylidene)‐3‐methylbutyl (ivDde) for amino groups and silyl protecting groups for alcohols [51]. The latter are removed using tetrabutylammonium fluoride. The wide variety of orthogonal protecting groups enables stepwise LSF at multiple sites directly on the resin, provided a suitable protecting group strategy is employed. While all canonical amino acids with Fmoc and standard side chain protection are commercially available in quantities of several tons, this is not the case for other side chain protecting groups, which must first be synthesized. Ideally, a selective reaction on unprotected peptides would be employed for reasons of chemical elegance and atom economy, but this is only possible for a handful of reactions, such as click reactions [52]. On‐Resin Nucleophilic Substitution Resin‐Bound Peptide as Nucleophile Nucleophilic groups are naturally present in peptides and proteins. These include amino groups in lysine, hydroxyl groups in serine and threonine, phenol groups in tyrosine and thionucleophiles in methionine and cysteine. Nucleophilic substitution is therefore a popular and powerful method for functionalizing peptides at a late stage of synthesis. Due to their high reactivity, strategies targeting cysteine side chains are the most frequently described. Many methods that allow peptide modification in solution have been reported, with maleimide conjugation being the most popular one [53, 54, 55]. On‐resin approaches offer good control over site selectivity due to the possibility of using orthogonal protecting group strategies (Chapter 2.2). In this context, De Luca et al. modified resin‐bound peptides containing cysteine residues via nucleophilic substitution of haloalkanes in an SN2 reaction in DMF with molecular sieves; the scope of the electrophiles also included lipids and fluorophores (Figure 2A) [56]. Likewise, Shinde et al. developed a method for trithioate formation starting from cysteine‐containing peptides. The reaction involves a nucleophilic addition to carbon disulfide, followed by a nucleophilic substitution on benzyl chloride derivatives (Figure 2B) [57]. In addition to cysteine, the lysine side chain or the N‐terminus of the peptide have been shown to also act as nucleophiles in this reaction, in which case dithioates are formed instead. On‐resin nucleophilic substitution of peptides with selected examples from the substrate scope. (A) Modification of cysteine‐containing peptides with bromoalkanes; (B) tri‐ and dithionate formation with benzyl chlorides and cysteine or lysine; (C) amine‐catalyzed tryptophan allylation; (D) alkylation of pyridyl side chains; (E) sulfilimine formation of N‐phenoxypeptidylamines; (F) nucleophilic aziridine‐opening; (G) nucleophilic substitution in iodohomoalanine residues with thiols; (H) amination of iodohomoalanine residues; (I) C‐terminal peptide modification by substitution of a cyclic urethane linker; (J) nucleophilic C‐terminal peptide modification after on‐resin benzotriazole formation. In general, N‐nucleophiles have frequently been targeted. Among these, amide formation reactions on lysine side chains and its lower homologs are particularly well‐established and popular [58]. Other N‐nucleophiles have been studied less frequently. One rare example is the DABCO‐catalyzed N‐allylation of the indole ring in tryptophan residues, as described by Liu et al. (Figure 2C) [59]. In addition to the nucleophiles that occur naturally in peptides, non‐canonical amino acids have also been employed in nucleophilic substitutions on resin. The group of Bandyopadhyay demonstrated N‐alkylation on pyridyl‐alanine (Figure 2D) [60]. The scope of substrates included complex electrophiles such as biotin and RGD peptide iodoacetamides. While the reaction worked well with halogen acetamides and benzyl halides, lower yields were obtained with less electrophilic haloalkanes. The amide of the peptide backbone can also be modified by nucleophilic substitution, for instance, using methyl iodide and sodium hydride as a base as shown by Ostresh et al. [20]. However, due to the harsh reaction conditions, only amino acids with aliphatic side chains and phenylalanine were tested and peptide epimerization was observed. White et al. reported on the N‐methylation of cyclic peptides using methyl iodide and lithium tert‐butoxide as a base, a method compatible with amino acid side chains that are protected as ethers or esters [61]. The N‐methylated products were obtained with high selectivity with the pattern of methylation being influenced by the stereochemistry and geometry of the peptide backbone, as well as by the choice of solvent. The modification of hydroxyl groups is a common method of introducing post‐translational modifications. Examples include the introduction of carbohydrates via Schmidt glycosylation, or phosphorylation using dibenzyl phosphochloridate or di‐tert‐butyl‐N,N‐diethylphosphoramidite [10, 11, 12, 13]. Nε ‐phosphorylation of lysine can also be achieved via a Staudinger phosphite reaction, as demonstrated by Hackenberger and co‐workers [62]. Modification of phenol groups via on‐resin tyrosine sulfation was demonstrated by Payne and co‐workers [63]. Resin‐Bound Peptide as Electrophile As mentioned above, electrophilic functional groups do not occur naturally in peptides and proteins. However, it has been demonstrated that electrophilic entities can be introduced into peptides at a late stage of synthesis, after which they are subjected to nucleophilic substitution reactions. One example is the sulfimidation of N‐phenoxypeptidylamines, as demonstrated by He et al. [64]. This process involves the coupling of O‐phenylhydroxylamine to a carboxylic group in aspartate or glutamate, followed by a reaction with diaryldisulfides. The group demonstrated the broad scope of substrates, including complex modifications such as biotin, flurbiprofen, and coumarin (Figure 2E). Galonić et al. reported a method of incorporating electrophilic groups into peptides that enables peptide modification without the formation of large linkers. More specifically, they incorporated aziridine‐2‐carboxylic acid into peptides, which were then reacted with thiols to form cysteine‐derived thioethers (Figure 2F) [16, 17]. Additional precautions were required to ensure the compatibility of the aziridine group with SPPS, such as using 1% 1,8‐diazabicyclo[5.4.0]undec‐7‐ene (DBU) in DMF for Fmoc deprotection, since the typical conditions of 20% piperidine in DMF led to aziridine ring opening and deacylation. The nucleophilic ring opening of the aziridine was controlled by adding catalytic amounts of DBU, enabling the reaction to proceed with high regioselectivity and yielding cysteine‐derived thioethers. Another example of nucleophilic substitution on resin‐bound peptide electrophiles is the iodination‐substitution approach described by the Thomas group (Figure 2G) [46]. In this approach, homoserine is incorporated into the desired peptide sequence using SPPS, with the side chain protected by the highly acid‐sensitive Dmt group. Following selective deprotection, homoserine is converted to iodohomoalanine in an Appel‐type reaction using the iodination reagent methyltriphenoxyphosphonium iodide (MTPI). The iodohomoalanine residue has been shown to react with various S‐nucleophiles, including the sterically hindered tert‐butyl mercaptan, mercaptocoumarin, and thioglucose. The use of amines was initially hampered by the competing elimination reaction. However, by changing the solvent from DMF to acetonitrile and adding formic acid, this side reaction could be minimized (Figure 2H) [36]. The procedure was feasible with various N‐nucleophiles, including primary and secondary amines, anilines and N‐heterocycles. Interestingly, substrates with multiple amino groups reacted only via one nucleophilic site, with no overalkylation or peptide cross‐linking observed. The iodination‐substitution approach was demonstrated on peptides of varying lengths, including a WW domain with 34 amino acids. Incidentally, there are reports of serine halogenation; however, the resulting haloalanine is highly susceptible to side reactions, including elimination, which can result in the formation of either dehydroalanine or 2‐oxazoline, as demonstrated by Meldal et al., whereby the formation of 2‐oxazolines represents an interesting example of an on‐resin backbone modification [18, 19]. Dehydroalanine can react as a Michael acceptor and be obtained on the solid phase via oxidative elimination of Se‐phenylselenocysteine with hydrogen peroxide. This process was demonstrated by van der Donk and co‐workers, who subsequently synthesized glycopeptides via Michael addition [22]. Nonetheless, the use of dehydroalanine as an electrophile has the disadvantage of diastereomer formation. An alternative strategy for introducing an electrophilic group to a resin‐bound peptide is the preparation of allenamide—an orthogonal handle for reacting with thiols – as reported by Brimble and colleagues [65]. C‐Terminal Modification In addition to side chain modifications, on‐resin nucleophilic substitution has been employed to introduce C‐terminal modifications. One simple way to achieve this is to prepare a side chain‐anchored peptide with an orthogonally protected C‐terminus, for example by incorporating Nα ‐allyl esters of glutamic or aspartic acid as C‐terminal amino acid building blocks. Using this approach, Ficht et al. introduced C‐terminal thioesters by coupling the carboxylic acid with thiols using N,N'‐diisopropylcarbodiimide, after orthogonally deprotecting the C‐terminus [66]. The Raj group reported C‐terminal modification via on‐resin formation of a cyclic urethane (Figure 2I) [67]. First, the C‐terminal serine is activated with N,N'‐disuccinimidyl carbonate (DSC) and converted into a cyclic urethane via nucleophilic attack on the amide backbone. The C‐terminus is then modified by nucleophilic substitution. This method can be used to synthesize C‐terminal esters, amides and alcohols. However, the scope of the tested nucleophiles was limited to water, methanol, and benzylamine as the publication focused on the production of macrocyclic peptides. More recently, Selvaraj et al. developed a method for the C‐terminal modification of peptides on the solid phase, which was inspired by C‐terminal thioester synthesis (Figure 2J) [68]. The key step of this approach is the mild conversion of the N‐acyl‐benzimidazoline linker to benzotriazole through treatment with isoamyl nitrite. The peptide is released from the resin through reaction with a nucleophile. C‐terminal modification was possible using water, alcohols, thiols and amines; even unreactive aniline yielded 66%. Notably, this method has also been applied in head‐to‐tail cyclization and the synthesis of longer peptides using other peptides as nucleophiles. It was also used for the C‐terminal addition of aminonitriles to produce macrocyclic thiazole peptides, demonstrating the versatility of this approach [69]. On‐Resin Carbonyl Chemistry Reductive Amination The natural abundance of N‐nucleophiles in peptides, whether located at the N‐terminus, the tryptophan indole ring or the lysine side chain, allows for carbonyl chemistry based on imine formation. Reductive amination on resin‐bound peptides has been employed in various studies, either utilizing the lysine side chain or the N‐terminus as the amine source [70, 71, 72, 73, 74, 75, 76, 77]. Most protocols employ an excess of aldehyde as the carbonyl compound, dissolved in dichloromethane or dichloroethane with acetic acid added. Na(OAc)3BH or, in some cases NaCNBH3, is subsequently used to reduce the imine to the corresponding amine. Dipyridylamine‐containing peptides synthesized in this way have a wide range of applications (Figure 3A) [75, 76]. An early example by Quinti et al. demonstrated the use of this technique to produce phosphatidylserine‐binding peptide ligands based on the phosphate‐sensitive properties of the Zn(II)‐dipicolylamine complex [70]. Zwicker et al. also applied this concept to produce fluorogenic peptide probes for phosphatidylserine on the cell surface [74]. Further applications from the He group include forming a Mn(I) carbonyl complex with a dipicolylamine‐containing peptide to enable light‐controlled release of CO, and designing an artificial metalloenzyme by mimicking the histidine brace of a lytic polysaccharide monooxygenase by incorporating a dipicolylamine motif into the active site of azurins [75, 76]. Catalytic activity of this minienzyme was characterized by a total turnover number of 253, a turnover rate of 1.61 min−1, and a Michaelis–Menten constant of 0.5 mM. On‐resin modification of peptides through carbonyl chemistry with selected examples from the substrate scope. (A) Lysine modification by reductive amination; (B) conversion of dimethyllysine to allysine followed by imination and reduction; (C) Ugi reaction at the peptide N‐terminus; (D) Petasis reaction on methyllysine; (E) Petasis reaction on tryptophan; (F) synthesis of imidazopyridinium macrocyclic peptides; (G) conversion of lysine to pyrraline. Reductive amination has also been applied with the resin‐bound peptide acting as the carbonyl source and an external amine. Aldehydes do not occur naturally in peptides and must therefore be introduced by either SPPS using unnatural amino acids or LSF. Chakraborty et al. introduced an aldehyde into the peptide side chain by oxidizing hydroxynorleucine on a resin‐bound N‐terminal H3 peptide with Dess–Martin periodinane (DMP) [71]. The resulting allysine was then modified by reductive amination. It should be noted that this method has only been demonstrated with one peptide, and that oxidation with DMP is incompatible with tryptophan residues [15]. More recently, Emenike et al. developed a new strategy for accessing allysine by converting dimethyllysine with Selectfluor on water‐swellable resin (Figure 3B) [78]. Allysine was then further modified with amines, hydrazines or hydroxylamines to produce the corresponding imino compounds. These were either isolated directly as iminopeptides in the case of the hydrazone or the oxime, or further reduced with NaCNBH3 to produce N‐alkylated products. Multicomponent Reactions Multicomponent reactions are highly valuable for discovering peptide therapeutics because they allow for a greater degree of diversification in the peptides produced [79]. The Ugi reaction is one such reaction that has proven useful for on‐resin multicomponent backbone N‐modification [80]. In this regard, Ricardo et al. reported the incorporation of isocyanides in the peptide backbone in combination with an aminocatalytic transimination of paraformaldehyde. This approach facilitated the use of formaldehyde as carbonyl component to prevent the formation of diastereomeric mixtures. Furthermore, the synthetic versatility of this platform was demonstrated by combining the Ugi reaction with subsequent backbone stapling, including ring‐closing metathesis, macrolactamization, and bis‐alkylation (Figure 3C). The same group also reported an optimized Petasis reaction on the solid phase for peptide modification [14, 81]. Their method involves subjecting methylated lysine side chains or the N‐terminus of a peptide to the Petasis reaction with a variety of aryl or vinyl boronic acids, as well as aldehydes or ketones (Figure 3D) [81]. Using a primary amine results in a doubly modified product. Similar to the aminocatalytic transimination used for the Ugi reaction, the introduction of formaldehyde can be elegantly solved through transimination with pyrrolidine, whereby the resulting pyrrolidinium ion transfers the formaldehyde group from paraformaldehyde to the resin‐bound amine. Krajcovicova et al. demonstrated that the Petasis reaction can also be applied to tryptophan [82]. The use of glyoxic acid as an aldehyde source introduces an additional carboxyl group, which can be used for further diversification through, for example, amide coupling (Figure 3E). N‐Heterocyclization Kodadek and co‐workers developed a method for forming imidazopyridinium macrocyclic peptides. First, the N‐terminal serine is oxidized to form an aldehyde, which then forms an imine with lysine. Next, 2‐formyl‐ or 2‐ketopyridines trap the reversible intramolecular imine to form an imidazopyridinium moiety (Figure 3F) [83]. This LSF works with a wide range of 2‐formyl‐ and 2‐ketopyridines, thereby leading to cyclic peptides with enhanced passive membrane permeability. Implementing piperazine‐containing 2‐formylpyridine enabled further modification via amide coupling to introduce fluorophore and biotin labels. The same group also described the formation of 2‐pyridone on resin via I2/acetone‐mediated condensation of 3,3‐methoxypropionic acid and amines [84, 85]. Pyrraline is an advanced glycation end‐product associated with retinopathy and nephropathy. To access this amino acid in peptides, Brimble and co‐workers converted lysine in collagen peptides to pyrraline through on‐resin Maillard‐type condensation with dihydropyranone (Figure 3G) [86]. While most examples of carbonyl chemistry used in the on‐resin LSF of peptides involve amines as reaction partners, there is one notable exception: an on‐resin Wittig olefination, which was demonstrated by Masri et al. [87] However, this is discussed in more detail in Chapter 7.2, as this strategy also involves a modification based on a 1,3‐cycloaddition. Generally, carbonyl chemistry is highly compatible with solid‐phase peptide chemistry. All the examples shown are applicable to large, complex peptides. On‐Resin Metal Catalyzed Reactions Cross‐Coupling Reactions The palladium‐catalyzed Suzuki–Miyaura cross‐coupling reaction (SMC) is one of the most widely used methods of forming C─C bonds, primarily because of the mild reaction conditions [88, 89]. It has therefore found its way into peptide chemistry [90]. Various groups, including Haug et al., Doan et al., and Limbach et al., have shown that resin‐bound oligopeptides containing up to seven residues and comprising 4‐iodophenylalanine and 4‐bromophenylalanine can be modified by SMC at elevated temperatures (50°C–90°C) overnight using a variety of boronic acids or boronates. Conversion rates of up to 90% have been achieved [91, 92, 93]. However, a greater variety of aryl halides are commercially available than boronic acid, which has driven the development of palladium‐catalyzed on‐resin borylation strategies for peptides containing 4‐iodophenylalanine and 3‐iodotyrosine as shown by Alfonso et al. (Figure 4A) [94, 95]. The resulting borylated peptides can undergo further modifications, such as the formation of cyclic peptides containing both borylated and halogenated aromatic amino acids. Due to its robustness and ease of execution, SMC is ideal for high‐throughput screening. Shasha et al. used 96‐well filter plates, which were originally developed for solid‐phase extraction, to create libraries of modified peptides [96]. Initially, this setup was employed to evaluate various reaction conditions for the on‐resin functionalization of pentapeptides containing 4‐bromophenylalanine or 5‐bromotryptophan (Figure 4B). The optimized conditions were then employed to synthesize a peptide library via functionalization with aromatic boronic acids or boronates. The SMC is not limited to aromatic amino acids. Jamieson et al. synthesized nonapeptides containing azidohomoalanine and pentynoic acid [97]. Copper‐catalyzed azide‐alkyne cycloaddition, in the presence of NBS as an oxidant, yielded a 5‐iodo‐1,4‐triazole cyclized peptide. This peptide was subsequently modified by SMC with aromatic pinacol boronates with very good to excellent conversion. Metal‐catalyzed reactions for on‐resin peptide modification. (A) Miyaura borylation of iodophenylalanine followed by SMC; (B) SMC with resin‐bound bromophenylalanine; (C) on‐resin Sonogashira reaction on iodophenylalanine; (D) deaminative cross‐coupling with pyridinium salts; (E) decarboxylative cross‐coupling with redox‐active esters; (F) C─H activation on resin‐bound tryptophan; (G) C─H activation on resin‐bound Nα ‐phthaloyl‐protected dehydroalanine. The Sonogashira reaction is a common method of forming C─C bonds in organic synthesis, involving the coupling of terminal alkynes and aryl halides in the presence of palladium and copper catalysts [98, 99]. In an example published by Doan et al., octapeptides containing 4‐iodophenylalanine were diversified via Sonogashira coupling with various alkynes, achieving good to excellent conversion (Figure 4C) [100]. Doebelin et al. achieved peptide diversification by coupling 4‐iodobenzoic acid to the N‐terminal position of a peptide which is then functionalized by Sonogashira reaction [101]. In addition to using artificial aromatic amino acid building blocks, on‐resin cross‐coupling reactions on canonical aromatic amino acids were also successfully carried out. One example was presented by the Chen group, who conducted copper‐catalyzed on‐resin heteroatom‐arylation on tryptophan, tyrosine and histidine side chains with various aryl diiodides for the purpose of peptide stapling [102]. The application of cross‐coupling reactions for on‐resin peptide LSF is not restricted to peptides containing aromatic amino acids as reaction handles. Twitty et al. showed that treatment of basic amino acids, such as lysine, ornithine, 2,4‐diaminobutyric acid and 2,3‐diaminopropanoic acid, with pyrilium salts converts the amino group of the side chain into a pyridinium group. This pyridinium group is susceptible to cross‐coupling with aryl bromides using a nickel catalyst (Figure 4D) [103]. The reaction was initially optimized for the modification of protected amino acids in solution, but it has also been demonstrated to be effective on the solid phase: a linear pentapeptide and a cyclic decapeptide were successfully modified, both containing mostly aliphatic and aromatic amino acids. The Baran group converted carboxyl groups on resin‐bound peptides, such as glutamic acid and aspartic acid, into redox active esters using the coupling reagent tetrachloro‐N‐hydroxyphthalimide tetramethyluronium hexafluorophosphate (CITU). The active esters then react with alkyl zinc reagents under nickel catalysis to form a C─C bond, releasing CO2 (Figure 4E) [104, 105]. The reaction was demonstrated on several resin‐bound bioactive peptides, including spinorphin, rubiscolin‐6 and β‐neoendorphin. C─H Activation Reactions Although the C─H activation of peptides in solution is well understood and extensively reported [106, 107, 108, 109, 110, 111], its application to resin‐bound peptides is rare. Ackermann and co‐workers demonstrated the modification of tryptophan residues through C─H activation, whereby the indole nitrogen is protected by a 2‐pyridyl group, which serves as a directing group for the ruthenium catalyst employed in this reaction (Figure 4F) [112]. Nona‐ and decapeptides containing mostly aliphatic amino acids were functionalized on resin, with arginine and glutamine residues also being tolerated. Furthermore, the peptide backbone has been shown to function as a directing group in C─H activation. Resin‐bound tripeptides containing an Nα ‐phthaloyl‐protected dehydroalanine residue have been shown to undergo modification with arylthianthrenium salts under palladium catalysis, producing dehydrophenylalanine analogs (Figure 4G) [113]. In this case, Dha acts as a nucleophile. Other Metal‐Catalyzed Reactions The most common copper‐catalyzed LSF of peptides on the resin is the azide‐alkyne cycloaddition. This well‐established reaction has been discussed in detail previously, so it will not be covered in this review [114]. A copper‐catalyzed reaction involving terminal alkynes, sulfonyl azides and amine nucleophiles results in the formation of amidines (Figure 5A) [115]. This reaction, described by the Kiran group, was used to either modify propargyl glycine‐containing dipeptides with a wide scope of aliphatic and aromatic amines or, conversely, lysine side chains with alkyne substrates. Furthermore, it has been demonstrated that the reaction can be used in the synthesis of cyclic tripeptides, in which the reaction occurs between a lysine residue and an alkyne‐containing amino acid. He et al. reported a ruthenium‐catalyzed sulfimidation of methionine residues using N‐acetoxyamides as substrates (Figure 5B) [116]. This method has proven suitable for side chain modification and peptide cyclization. Pentapeptides containing a methionine residue and an allyl‐protected glutamate residue can be cyclized using the ruthenium catalyst [RuCl2(PPh3)3]. Prior to cyclization, the allyl‐protected glutamate residue is selectively transformed into the required N‐acetoxyamide substrate via allyl deprotection followed by O‐acetylhydroxylamine coupling. Metal‐catalyzed reactions for on‐resin peptide modification. (A) Ketenimine multicomponent reaction on resin‐bound propargylglycine or lysine; (B) methionine‐selective sulfimidation; (C) on‐resin oxime‐ether formation followed by reaction with 2H‐azirines; (D) regioselective hydroboration on resin‐bound propargylglycine and allylglycine; (E) A3‐coupling on alkyne‐containing peptides; (F) decarboxylative Giese‐type reaction; (G) lysine‐based pyrrole formation. The Cu(I)‐catalyzed reaction between N‐methoxyamides and 2H‐azirines results in the formation of oxime ethers. This reaction has been used to introduce fluorescent labels to resin‐bound peptides (see Figure 5C) [117]. Liu et al. incorporated a glutamate building block during SPPS that was orthogonally protected as an allyl ester in the side chain. This was then coupled with methoxyamine after palladium‐mediated selective deprotection, resulting in the formation of the corresponding methoxyamide. Subsequent reaction with 2H‐azirine‐containing coumarin gave the functionalized pentapeptide. Propargylglycine has proven to be a useful and cost‐effective building block for enabling the LSF of peptides on the solid phase. For example, propargylglycine has been used as a reactive handle in on‐resin ruthenium‐catalyzed hydroboration, which results in the formation of vinylboronic acids (Figure 5D) [38]. Werner et al. used [Cp*Ru(PPh3)2Cl] as a catalyst and pinacol borane as a substrate, demonstrating high selectivity in the formation of (E)‐vinylboronic acids. While a more air‐stable iridium catalyst produces a mixture of regioisomers in the hydroboration of propargylglycine‐modified resins, it is highly effective in the on‐resin hydroboration of allylglycine‐containing peptides, resulting in the respective aliphatic boronic acids. The group demonstrated the general applicability of this approach to various boronates and peptides of up to 58 amino acids in length, achieving good to excellent yields in the reaction. Notably, peptide boronic acids are of great interest in the development of new peptide therapeutics, since these compounds are known to form reversible covalent bonds with naturally occurring diols, such as carbohydrates [118]. Additionally, vinylboronic acids are valuable starting materials for further peptide modification, e.g., through SMC or Petasis reaction. The reaction between a terminal alkyne, an aldehyde and an amine to form propargylamines, known as A3 coupling [119], has also found its way into on‐resin peptide LSF (Figure 5E). Lubell and co‐workers used aza‐propargylglycine building blocks, secondary amines and formaldehyde that reacted under copper catalysis to form aza‐lysine analog‐containing hexapeptides [120, 121]. The reaction is compatible with several secondary amines, including sterically hindered side chains, such as isopropyl or cyclohexyl residues. Cyclic azapeptides are formed in a copper‐catalyzed reaction with formaldehyde when the aza‐propargylglycine is positioned at the N‐terminus and the N‐alkylated lysine at the C‐terminus of the peptide sequence [122]. Similar to the aforementioned decarboxylative cross‐coupling reaction, the Baran group used redox‐active esters in a nickel‐catalyzed Giese‐type reaction on the resin (Figure 5F) [123]. In the Giese reaction, alkyl radicals react with Michael acceptors in a 1,4‐addition. As an alternative to light, these radicals can be generated by nickel‐catalyzed decarboxylation of N‐hydroxyphthalimide active esters. This variant of the Giese reaction was employed to functionalize carboxylic groups in resin‐bound tripeptides, including glutamate side chains and the free C‐terminus. It was also demonstrated that the amino groups in the lysine side chains could be selectively modified with acrylic acid followed by further conversion to cross‐linked peptides by stapling with N‐hydroxyphthalimide active ester modified amino acids. Although radicals are formed during the reaction, tyrosine was tolerated. Other sensitive amino acids were not tested. The Albericio group employed a microwave‐assisted multicomponent condensation reaction involving a β‐nitrostyrene, a 1,3‐dicarbonyl compound and a free lysine side chain to modify resin‐bound peptides with pyrroles (Figure 5G) [124]. The reaction is catalyzed by FeCl3 as a Lewis acid; however, other Lewis acids, such as zinc and aluminium salts, have been shown not to catalyze the reaction. The scope was demonstrated on a lysine‐containing tripeptide. The reaction produces high‐purity crude products and has been shown to be versatile, enabling a variety of pyrroles to be introduced into peptides. On‐Resin Redox Reactions So far, redox reactions have rarely been used for on‐resin peptide modification. This is most likely due to the risk of side reactions, such as tryptophan, cysteine and methionine oxidation. This was observed during Dess–Martin periodinane‐mediated oxidation of threonine side chains, as reported by the Meldal group in their studies on pyrazine formation on the solid phase (Figure 6A) [15]. The on‐resin oxidation of hydroxynorleucine in an N‐terminal H3 peptide, as mentioned previously, demonstrates that DMP‐mediated oxidation can be applied to more complex peptides [71]. The Qvortrup group reported a selective oxidative backbone cyclization involving the formation of an oxazole between the backbone and the indole side chain of tryptophan, using 2,3‐dichloro‐5,6‐cyano‐1,4‐benzoquinone (DDQ) as the oxidizing agent (Figure 6B) [125]. The cyclodehydration results in a fully conjugated indolyl‐oxazole that shows blue fluorescence. It has also been demonstrated that the method is applicable to complex peptides such as GLP‐1. The research conducted by the Waser group on hypervalent iodine reagents clearly demonstrates the benefits of redox reactions in bioorganic chemistry [126]. Ethinylbenziodoxolones react with thiols, such as cysteine, to form thioalkynes (Figure 6C). During peptide cleavage from the resin using trifluoroacetic acid, the thioalkyne is converted into a thioester. However, when synthesized on a trityl resin, cleaving the peptide with hexafluoroisopropanol prevents this conversion, leaving the thioalkyne moiety intact and available for a ruthenium‐catalyzed click reaction with azides. Redox reactions on resin‐bound peptides. (A) Oxidation of threonine side chains followed by pyrazine formation; (B) tryptophan‐selective oxazole formation; (C) thioalkyne formation with ethinylbenziodoxolones. Redox reactions hold great potential for modifying peptides on the solid phase. We anticipate that more strategies based on this chemistry will emerge in the future. One recent development in this area is the use of photoredox reactions, which will be discussed in detail in Chapter 8. On‐Resin Pericyclic Reactions Inverse Electron Demand Diels–Alder Reaction Pericyclic reactions are commonly used in bioorganic chemistry for labeling purposes owing to their biorthogonal nature. A prominent example is the inverse electron demand Diels–Alder reaction (IEDDA), which uses electron‐deficient tetrazine compounds as dienes and electron‐rich dienophiles [127]. While this reaction can be performed post‐synthetically in water, eliminating the need to protect other peptide functional groups, the solid phase offers advantages such as avoiding solubility and stability issues of the hydrophobic tetrazine and simplifying purification steps. For this reason, Pagel et al. incorporated a tetrazine into a peptide on resin to attach RGD peptides via IEDDA using four types of dienophiles, including Reppe dienophiles, maleimides, alloc and allyl moieties [128]. The respective conjugates were either cleaved directly from the resin or further oxidized with isoamyl nitrite to yield pyridazines (Figure 7A). On‐resin pericyclic reactions on resin‐bound peptides. (A) IEDDA with resin‐bound peptide tetrazines; (B) tyrosine triazine ligation strategy; (C) phosphoranylidene‐based cycloaddition with azides followed by Wittig reaction with aldehydes; (D) N‐terminal triazolobenzodiazepine formation; (E) on‐resin cycloaddition on Dha residues with azomethins. IEDDA can also be used for peptide diversification, as demonstrated by Zuo et al. in their tyrosine‐triazine ligation (Figure 7B) [129]. First, a 1,2,3‐triazine was introduced into a tyrosine side chain. Next, the triazine was modified by IEDDA using various dienophiles, thereby producing either pyridine or pyrimidine moieties. The on‐resin approach allows for parallelization, which was performed in a microplate setup to generate a library of 384 compounds for screening amphiphilic antibacterial peptides. 1,3‐Dipolar Cycloaddition Masri et al. developed an LSF approach based on the derivatization of a readily accessible phosphoranylidene amino acid from aspartate (Figure 7C) [87]. The resin can be modified by either Wittig olefination with aldehydes or metal‐free 1,3‐dipolar cycloaddition with azides, in order to selectively obtain the 1,5‐triazole. In both cases, the resin is heated in THF with DIPEA for 18 h at 70°C. The compatibility of the unnatural phosphoranylidene amino acid with the standard conditions of SPPS (Fmoc deprotection, amino acid coupling, N‐terminal acetylation) was demonstrated. Although the largest peptide in the scope was only a hexamer, it included serine, glutamate, glutamine, and tyrosine, giving it a relatively high level of complexity. Kamble et al. employed metal‐free on‐resin triazole formation for the N‐terminal generation of triazolobenzodiazepines, a notable heterocycle with therapeutic potential (Figure 7D) [130]. The propargyl group is introduced at the N‐terminus of the peptide through a Mitsunobu reaction using propargyl alcohol. Subsequent formation of the amide bond with ortho‐azidobenzoic acid derivatives and azide‐alkyne cycloaddition proceed without the use of a copper catalyst. This reaction has also been demonstrated using lysine side chains as the amine component. Dha has also proven to be a valuable building block in the modification of peptides via 1,3‐dipolar cycloaddition. Bao et al. exploited its unique electronic properties, which arise from the electronic properties of the adjacent π‐donating nitrogen and electron‐withdrawing carbonyl group, to introduce C,N‐cyclic azomethins (Figure 7E) [131]. The regioselectivity was controlled via the N‐terminal protecting group of Dha. N‐bi‐protected Dha undergoes a 1,3‐cycloaddition with standard electron demand, whereas Fmoc‐protected Dha undergoes a 1,3‐cycloaddition with inverse electron demand. This enables control over the formation of different isomers. On‐Resin Photocatalysis Decarboxylative C─C Bond Formation Photocatalyzed reactions have become increasingly important in organic chemistry, subsequently extending to the solid phase [132]. The Molander group were the first to demonstrate the compatibility of photocatalysis with peptide modification on solid supports, including redox‐sensitive amino acids tryptophan, histidine, cysteine, and methionine, as evidenced by decarboxylative hydroalkylation of resin‐bound Giese acceptors catalyzed by iridium‐based photocatalysts or Hantzsch esters (Figure 8A) [133]. The same group then adopted a different approach, forming redox‐active N‐hydroxyphthalimide (NHPI) esters with aspartic and glutamic acids on resin‐bound peptides [134]. This resulted in the formation of an electron donor–acceptor complex with a Hantzsch ester, producing alanyl and homoalanyl radicals via photoinduced single‐electron transfer (Figure 8B). These radicals then reacted with either allyl acrylate or styrene, resulting in the formation of homologs of either glutamic acid or phenylalanine. The ‘t Hart group demonstrated the decarboxylative arylation of redox‐active NHPI esters of aspartic and glutamic acids on resin‐bound peptides using a variety of aryl bromides, yielding phenylalanine and homophenylalanine derivatives (Figure 8C) [37]. Unlike the other reactions shown in this chapter that use blue light, the Hantzsch ester photocatalytic reaction involved the use of a nickel catalyst and a purple LED. Photocatalyzed peptide modifications on the solid phase. (A) Hydroalkylation of resin‐bound Giese acceptors with redox‐active NHPI esters; (B) Giese‐type reaction with resin‐bound redox‐active NHPI esters; (C) decarboxylative arylation with resin‐bound redox‐active NHPI esters; (D) deaminative C─C bond formation with resin‐bound Katritzky salts; (E) deoxygenative radical addition with resin‐bound dehydroalanine; (F) N‐arylation of resin‐bound tryptophan; (G) three‐component atom‐transfer radical addition with resin‐bound disulfide‐protected cysteine. Photocatalyzed Deamination and Deoxygenation Katritzky salts have been shown to be valuable starting materials for C─C bond formation. They can be generated from lysine or shorter homologs by converting the amino group with pyrylium salts (Figure 8D) [135]. Openy et al. used the resulting Katritzky salts in a photochemical deaminative alkylation, in which an electron donor–acceptor complex forms between a Hantzsch ester and the salt. When irradiated with blue light, the C─N bond undergoes homolytic cleavage to generate a carbon radical, which then reacts with a Michael acceptor. The scope includes a large variety of Michael acceptors and the method proved to be compatible with 15 amino acid residue peptides. A classical Michael acceptor that can be incorporated into peptides is the amino acid Dha, which reacts with radicals in an addition reaction (Figure 8E) [136]. However, since Michael acceptors can also react with nucleophiles such as piperidine, Bao et al. used disulfide‐protected cysteine as a Dha precursor. Selective deprotection, followed by elimination with potassium carbonate and 1,4‐dibromobutane, produced Dha, which then reacted with carbonyl radicals. These radicals were generated by reacting an aryl carboxylic acid with triphenylphosphine in the presence of an iridium photocatalyst and blue light. Photocatalyzed Heteroatom Functionalization The selective N‐modification of tryptophan can be challenging due to the presence of several other reactive positions in the indole ring. Selective N‐arylation on the resin was achieved by Delgado et al. using a nickel‐dtbbpy complex and 1,2,3,5‐tetrakis(carbazol‐9‐yl)‐4,6‐dicyanobenzene (4‐CzIPN) as a photocatalyst, with a variety of aryl bromides serving as substrates, under blue light irradiation (Figure 8F) [137]. This reaction was shown to be compatible with all canonical amino acids bearing the common protecting groups for Fmoc‐SPPS, making it extremely useful for functionalizing bioactive peptides. The authors were able to selectively functionalize linear and disulfide‐cyclized somatostatin, melittin, glucagon, and others. As previously mentioned, cysteine is a very useful amino acid for LSF. Using an iridium photocatalyst under blue light irradiation, resin‐bound peptides containing a disulfide‐protected cysteine residue were reacted with phenylacetylene and a sulfinate‐containing dye to obtain a redox‐sensitive fluorescent probe (Figure 8G) [138]. This atom‐transfer radical addition reported by Liu et al. yielded various (E)‐β‐alkylsulfonylvinyl alkylsulfides. These dyes exhibit blue fluorescence in the oxidized state and green fluorescence in the reduced state. When combined with cell‐penetrating peptides, the redox state of cells can be visualized using fluorescence microscopy. Late‐Stage Functionalization and Peptide Drug Development On‐resin LSF offers great potential for developing peptide drugs. Incorporating non‐canonical amino acids into potential therapeutic peptides can improve their efficacy and pharmacokinetics [7]. The advantages of on‐resin peptide LSF are that non‐canonical amino acids can be introduced in a time‐ and cost‐efficient manner, and in parallel formats. While most of the research highlighted in this review focuses on developing chemical methods for LSF, in some studies the developed approaches are used to improve properties of potential peptide therapeutics and even highlight LSF in the development of peptide drugs in parallel formats. Strategies that improve the properties of biologically active peptides include peptide cyclization and stapling. Krajcovicova et al. used the Petasis reaction on the tryptophan side chain (Chapter 4.2) to staple the cell adhesion motifs KQAGDV (muscle cell adhesion) and DGEA (α2β1 integrin receptor) [82]. They were then able to demonstrate pre‐organization of the biologically active conformation and improved biostability compared to the linear counterparts. Lubell and colleagues also used stapling via an A3 coupling to produce peptidomimetics that modulate the activity of the multifunctional cluster of differentiation 36 (CD36) scavenger receptor [122]. From a small library of stapled peptides, they identified peptide ligands with IC 50 values at submicromolar concentrations. However, peptide diversification was achieved by varying the peptide sequence rather than LSF. An interesting example of how the pharmacokinetics of peptides can be improved through LSF is the introduction of an imidazopyridinium group into the backbone of peptide macrocycles, as described by Bo et al. (Chapter 4.3) [83]. Despite having molecular weights greater than 500 Da, macrocyclic peptides containing the imidazopyridinium group exhibited excellent membrane permeability. Furthermore, the extent of membrane permeability could be adjusted by varying the substituents at the imidazopyridinium modification. The main potential of on‐resin peptide LSF is its application in peptide diversification in parallel formats to produce peptide libraries. In a small scale, this was demonstrated by Doan et al. who used Sonogashira coupling on resin‐bound peptides [100]. They identified two peptide variants with improved bioactivity from a set of 10 peptide derivatives of pituitary adenylate cyclase‐activating polypeptide (PACAP), a neuroprotective hormone (Chapter 5.1). Shasha et al. demonstrated that high‐throughput experimentation in an on‐resin SMC in a 96‐well plate format can be used to create large peptide libraries for screening for therapeutic potential (Chapter 5.1) [96]. Zuo et al. took this a step further by using tyrosine‐1,2,3‐triazine ligation on resin‐bound peptides – a reaction sequence consisting of electrophilic aromatic substitution and IEDDA – and applying this method to the high‐throughput synthesis of a library of 384 antimicrobial peptides in a 96‐well plate format, thereby identifying a candidate with good activity against Gram‐positive bacteria [129]. This impressive example demonstrates the potential of late‐stage peptide modification in streamlining peptide drug discovery. Conclusions Over the past decade, we have witnessed the evolution of SPPS, which has progressed from simple peptide sequence assembly to enabling the introduction of non‐canonical modifications in the late stages of the synthetic process. Many classic organic reactions can now be performed on the solid support, which makes diversifying peptides simple and cost‐efficient. This opens new possibilities for peptide drug development. Consequently, the potential for late‐stage diversification through the selective modification of amino acid residues in peptide sequences is becoming increasingly recognized. The main advantage of site‐selective peptide modification on the solid phase is the possibility of parallelizing this process, enabling the development of high‐throughput experiments and the straightforward synthesis of peptide libraries. Some of the contributions in this field provide a glimpse of this potential, particularly the examples demonstrating high‐throughput peptide diversification in 96‐well plate formats [96, 129]. Although this development is still in its infancy, we believe that the potential of on‐resin late‐stage peptide diversification will be unleashed in the next years, especially when combined with the computational tools currently being developed to predict the interaction of modified peptides with therapeutic targets [139]. However, much work remains to be done. The range of organic reactions suitable for LSF that are also compatible with a broad scope of peptides needs to be expanded to allow greater structural flexibility in the modifications introduced. This also involves the further development of experimental setups that facilitate the synthesis and characterization of peptides in parallel formats under different conditions, including photochemistry and electrochemistry. Author Contributions Marius Werner: writing – original draft, conceptualization, writing – review and editing. Truc Lam Pham: writing – original draft, writing – review and editing, conceptualization. Franziska Thomas: writing – original draft, writing – review and editing, conceptualization. Funding Dieter Schwarz Foundation, Max‐Planck‐Gesellschaft, Ministerium für Wissenschaft, Forschung und Kunst Baden‐Württemberg, Bundesministerium für Bildung und Forschung, Deutsche Forschungsgemeinschaft, https://doi.org/10.13039/501100013368, Max Planck School Matter to Life, Deutsche Akademie der Naturforscher Leopoldina ‐ Nationale Akademie der Wissenschaften Conflicts of Interest The authors declare no conflicts of interest. Supporting information Supporting File: anie72996‐sup‐0001‐SupMat.pdf. We have added a small guideline of practical considerations as supplementary material. The authors have cited additional references within the Supporting Information [140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162]. Acknowledgements T. L. P. is grateful for the Leopoldina postdoc scholarship (Grant number: LPDS 2025‐04) provided by the Deutsche Akademie der Naturforscher Leopoldina – German National Academy of Sciences. This work was funded by the Federal Ministry of Education and Research (BMBF) and the Ministry of Science Baden‐Württemberg within the framework of the Excellence Strategy of the Federal and State Governments of Germany (ExU 6.1.16.3) and by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy – EXC‐3018/1 – 533587280. This study was conducted within the Max Planck School Matter to Life, supported by the Dieter Schwarz Foundation and the German Federal Ministry of Education and Research (BMBF) in collaboration with the Max Planck Society. Open access funding enabled and organized by Projekt DEAL. Biographies Marius Werner obtained his Bachelor's and Master's degree in chemistry at Heidelberg University, where he completed his Master thesis under the supervision of Franziska Thomas. As a joint PhD student of Franziska Thomas and Christian Klein, he develops novel strategies for peptide modification aimed at engineering peptide vaccines for cancer immunotherapy. Truc Lam Pham studied biochemistry and chemistry at the University of Göttingen and completed his PhD at Heidelberg University in 2024 with Franziska Thomas, designing metal‐binding β‐sheet miniproteins. He then conducted postdoctoral research with Peter Comba on copper‐binding small‐molecule drugs and patellamide derivatives. Currently, he is a postdoc at the Australian National University with Gottfried Otting and Christoph Nitsche, developing lanthanide‐binding peptide tags for paramagnetic NMR spectroscopy. Franziska Thomas studied chemistry at Humboldt University in Berlin, receiving her PhD in 2010. Following a postdoctoral stay at the University of Bristol in the UK, where she worked with Dek Woolfson, she became an independent research group leader at the University of Göttingen. In 2019, she moved to Heidelberg University as a tenure‐track professor and was promoted to full professor of organic chemistry in 2025. Her research interests include the de novo design of miniproteins and developing new methods for late‐stage peptide functionalization, with applications in peptide therapeutics and peptide catalysts. Dedicated to Oliver Seitz on the occasion of his 60th birthday. Data Availability Statement This is not relevant, since the manuscript is a review. References Associated Data Supplementary Materials Supporting File: anie72996‐sup‐0001‐SupMat.pdf. We have added a small guideline of practical considerations as supplementary material. The authors have cited additional references within the Supporting Information [140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162]. Data Availability Statement This is not relevant, since the manuscript is a review.